Pablo Valderrabano

10PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)South-East Asian literature (excl. Indonesian)AutoimmunityAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 28, 2026
Outcomes of patients with low-risk differentiated thyroid cancer with an excellent response to initial therapy.

|Aug 08, 2026
Determinants of physicians' risk-benefit perceptions of adjuvant radioactive iodine for differentiated thyroid cancer.

|Feb 17, 2025
Evaluation of thyroid ultrasound reports' quality in the Community of Madrid, Spain.

Pablo Valderrabano, Jhonatan Boris Quiñones Silva, Sandra Campos Mena

|May 22, 2023
Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.

Noemi Brox-Torrecilla, Ana M García Cano, Pablo Valderrábano

|Jan 30, 2023
Clinical value of molecular markers as diagnostic and prognostic tools to guide treatment of thyroid cancer.

Pablo Valderrabano, Markus Eszlinger, Paul Stewardson

|Oct 24, 2022
Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.

Marta Araujo-Castro, Ana M García Cano, Héctor F Escobar-Morreale

Pageof 2

Frequent Collaborators

5 joint publications

Marta Araujo-Castro

3 joint publications

Jhonatan Quiñones-Silva

2 joint publications

Noemi Brox-Torrecilla

2 joint publications

Carlos Garcia-Regal